Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v2.4.1.9
CONSOLIDATED BALANCE SHEETS (USD $)
Dec. 31, 2014
Dec. 31, 2013
Current assets    
Cash $ 623us-gaap_Cash   
Total current assets 623us-gaap_AssetsCurrent   
Fixed assets - net 454us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment 1,230us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
Total Assets 1,077us-gaap_Assets 1,230us-gaap_Assets
Current liabilities    
Accounts payable 484,260us-gaap_AccountsPayableCurrent 421,597us-gaap_AccountsPayableCurrent
Accrued interest payable 407,684us-gaap_InterestPayableCurrent 268,950us-gaap_InterestPayableCurrent
Notes payable - current - related parties 697,225us-gaap_NotesPayableRelatedPartiesClassifiedCurrent 573,516us-gaap_NotesPayableRelatedPartiesClassifiedCurrent
Notes payable - current, net 871,694us-gaap_NotesPayableCurrent 612,342us-gaap_NotesPayableCurrent
Notes payable - derivitive liability payable 25,456us-gaap_DerivativeLiabilities 150,067us-gaap_DerivativeLiabilities
Stock subscription payable - current 28,067IMLE_StockSubscriptionPayableCurrent 26,000IMLE_StockSubscriptionPayableCurrent
Related party payables 296,265us-gaap_AccountsPayableRelatedPartiesCurrent 190,765us-gaap_AccountsPayableRelatedPartiesCurrent
Other payables 241,922us-gaap_AccountsPayableOtherCurrent 238,085us-gaap_AccountsPayableOtherCurrent
Total current liabilities 3,052,573us-gaap_LiabilitiesCurrent 2,481,322us-gaap_LiabilitiesCurrent
Notes payable - related parties 43,298us-gaap_NotesPayableRelatedPartiesNoncurrent 167,007us-gaap_NotesPayableRelatedPartiesNoncurrent
Total Liabilities 3,095,871us-gaap_Liabilities 2,648,329us-gaap_Liabilities
Stockholders' Deficit    
Common stock, $.00001 par value; 100,000,000 shares authorized; 58,416,660 and 34,146,712 shares issued and outstanding as of December 31 2014 and 2013, respectively 585us-gaap_CommonStockValue 342us-gaap_CommonStockValue
Additional paid in capital 12,716,630us-gaap_AdditionalPaidInCapital 12,415,639us-gaap_AdditionalPaidInCapital
Accumulated deficit (15,777,222)us-gaap_RetainedEarningsAccumulatedDeficit (15,032,660)us-gaap_RetainedEarningsAccumulatedDeficit
Total Transbiotec, Inc. stockholders' deficit (3,060,007)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest (2,616,679)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Noncontrolling interest (34,787)us-gaap_MinorityInterest (30,420)us-gaap_MinorityInterest
Total Stockholders' Deficit (3,094,794)us-gaap_StockholdersEquity (2,647,099)us-gaap_StockholdersEquity
Total Liabilities and Stockholders' Deficit $ 1,077us-gaap_LiabilitiesAndStockholdersEquity $ 1,230us-gaap_LiabilitiesAndStockholdersEquity